{
     "PMID": "7883034",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "19950410",
     "LR": "20131121",
     "IS": "0014-2999 (Print) 0014-2999 (Linking)",
     "VI": "265",
     "IP": "1-2",
     "DP": "1994 Nov 14",
     "TI": "Binding profile of benextramine at neuropeptide Y receptor subtypes in rat brain areas.",
     "PG": "93-8",
     "AB": "Binding studies in rat whole brain, frontoparietal cortex and brainstem membrane preparations revealed that benextramine displaced [3H]neuropeptide Y specific binding from a low and a high affinity site with IC50 values in the microM (36 +/- 2, 4.4 +/- 1.4 and 300 +/- 120 microM, respectively) and the pM (29.3 +/- 12.1, 0.35 +/- 0.11 and 0.42 +/- 0.03 pM, respectively) range, whereas in rat hippocampus benextramine displaced [3H]neuropeptide Y specific binding from one site only with an IC50 value of 22.8 +/- 5.7 microM. With the exception of frontoparietal cortex binding assay, benextramine was not able to completely inhibit [3H]neuropeptide Y specific binding revealing the presence of a benextramine nonsensitive third binding site. Benextramine pretreatment followed by membrane washing demonstrated that benextramine inhibited irreversibly both high and low affinity sites.",
     "FAU": [
          "Melchiorre, C",
          "Romualdi, P",
          "Bolognesi, M L",
          "Donatini, A",
          "Ferri, S"
     ],
     "AU": [
          "Melchiorre C",
          "Romualdi P",
          "Bolognesi ML",
          "Donatini A",
          "Ferri S"
     ],
     "AD": "Department of Pharmaceutical Sciences, University of Bologna, Italy.",
     "LA": [
          "eng"
     ],
     "PT": [
          "Journal Article",
          "Research Support, Non-U.S. Gov't"
     ],
     "PL": "Netherlands",
     "TA": "Eur J Pharmacol",
     "JT": "European journal of pharmacology",
     "JID": "1254354",
     "RN": [
          "0 (Adrenergic alpha-Antagonists)",
          "0 (Diamines)",
          "0 (Receptors, Neuropeptide Y)",
          "102974-82-3 (CM 178-78)",
          "69790-18-7 (benextramine)",
          "R110LV8L02 (Cystamine)"
     ],
     "SB": "IM",
     "MH": [
          "Adrenergic alpha-Antagonists/*metabolism/pharmacology",
          "Animals",
          "Binding, Competitive",
          "Brain/drug effects/*metabolism",
          "Brain Stem/drug effects/metabolism",
          "Computer Simulation",
          "Cystamine/*analogs & derivatives/metabolism/pharmacology",
          "Diamines/metabolism/pharmacology",
          "Frontal Lobe/drug effects/metabolism",
          "Hippocampus/drug effects/metabolism",
          "Male",
          "Parietal Lobe/drug effects/metabolism",
          "Radioligand Assay",
          "Rats",
          "Rats, Sprague-Dawley",
          "Receptors, Neuropeptide Y/drug effects/*metabolism"
     ],
     "EDAT": "1994/11/14 00:00",
     "MHDA": "1994/11/14 00:01",
     "CRDT": [
          "1994/11/14 00:00"
     ],
     "PHST": [
          "1994/11/14 00:00 [pubmed]",
          "1994/11/14 00:01 [medline]",
          "1994/11/14 00:00 [entrez]"
     ],
     "AID": [
          "0014-2999(94)90228-3 [pii]"
     ],
     "PST": "ppublish",
     "SO": "Eur J Pharmacol. 1994 Nov 14;265(1-2):93-8.",
     "term": "hippocampus"
}